Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,478 | 69 | 98.6% |
| Education | $21.00 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SI-BONE, INC. | $185.80 | 4 | $0 (2024) |
| Avanos Medical | $183.01 | 4 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $169.27 | 10 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $122.38 | 7 | $0 (2023) |
| Boston Scientific Corporation | $109.21 | 6 | $0 (2022) |
| Lundbeck LLC | $78.71 | 3 | $0 (2024) |
| Abbott Laboratories | $76.36 | 3 | $0 (2023) |
| Horizon Pharma plc | $71.47 | 4 | $0 (2017) |
| ARBOR PHARMACEUTICALS, INC. | $67.35 | 5 | $0 (2021) |
| Purdue Pharma L.P. | $64.03 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $213.98 | 10 | Lundbeck LLC ($78.71) |
| 2023 | $276.76 | 15 | Kowa Pharmaceuticals America, Inc. ($81.38) |
| 2022 | $126.70 | 7 | Kowa Pharmaceuticals America, Inc. ($41.00) |
| 2021 | $238.40 | 8 | SI-BONE, INC. ($140.25) |
| 2018 | $241.75 | 7 | Avanos Medical ($163.63) |
| 2017 | $401.28 | 23 | Horizon Pharma plc ($71.47) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/13/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.72 | General |
| Category: Opioid Analgesic | ||||||
| 09/24/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.66 | General |
| Category: Opioid Analgesic | ||||||
| 09/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.54 | General |
| Category: NEUROLOGY | ||||||
| 08/08/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $27.73 | General |
| Category: NEUROLOGY | ||||||
| 07/25/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $15.09 | General |
| Category: Opioid Analgesic | ||||||
| 07/23/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device), Zilretta | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Pain Management | ||||||
| 07/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $27.44 | General |
| Category: NEUROLOGY | ||||||
| 05/01/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $18.68 | General |
| 01/16/2024 | Avanos Medical | STANDARD RF DISPOSABLES (Device) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/18/2023 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/08/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.82 | General |
| Category: Opioid Analgesic | ||||||
| 10/25/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: Neuromodulation | ||||||
| 10/17/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device), Zilretta | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Pain Management | ||||||
| 09/11/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Neuromodulation | ||||||
| 08/16/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.18 | General |
| Category: Opioid Analgesic | ||||||
| 07/11/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/06/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/05/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: Opioid Analgesic | ||||||
| 06/01/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: VACCINES | ||||||
| 05/18/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Neuromodulation | ||||||
| 05/09/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/27/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: PAIN | ||||||
| 02/14/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/03/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,866 | 6,158 | $1.8M | $673,158 |
| 2022 | 27 | 2,004 | 4,717 | $1.3M | $516,691 |
| 2021 | 26 | 1,335 | 3,421 | $929,462 | $377,436 |
| 2020 | 24 | 1,017 | 2,130 | $1.2M | $192,877 |
All Medicare Procedures & Services
129 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 307 | 1,330 | $364,248 | $139,106 | 38.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 118 | 157 | $224,058 | $69,875 | 31.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 141 | 270 | $132,402 | $59,787 | 45.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 153 | 214 | $101,034 | $47,069 | 46.6% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 118 | 167 | $106,082 | $40,422 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 174 | 436 | $83,172 | $32,981 | 39.7% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 140 | 266 | $65,446 | $30,613 | 46.8% |
| 64451 | Injection of anesthetic agent and/or steroid into spine and pelvis nerve using imaging guidance | Office | 2023 | 51 | 93 | $56,451 | $27,296 | 48.4% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 52 | 98 | $47,604 | $23,830 | 50.1% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 97 | 226 | $64,410 | $23,389 | 36.3% |
| 64625 | Destruction of nerves supplying joint between spine and pelvis using imaging guidance | Office | 2023 | 31 | 38 | $54,568 | $19,006 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 143 | 143 | $59,345 | $18,481 | 31.1% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 57 | 81 | $38,313 | $18,279 | 47.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 64 | 82 | $40,836 | $17,247 | 42.2% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 30 | 43 | $69,738 | $15,931 | 22.8% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 59 | 63 | $28,138 | $12,290 | 43.7% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 52 | 97 | $23,075 | $12,049 | 52.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 85 | 195 | $27,300 | $11,121 | 40.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 137 | 252 | $37,800 | $10,901 | 28.8% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 30 | 44 | $30,325 | $9,722 | 32.1% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 62 | 81 | $19,288 | $7,809 | 40.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 53 | 73 | $8,760 | $5,687 | 64.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 40 | 43 | $7,310 | $4,510 | 61.7% |
| 01940 | Anesthesia for nerve destruction procedures on spine or spinal cord of lower back accessed through skin using imaging guidance | Office | 2023 | 32 | 38 | $12,866 | $3,513 | 27.3% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 39 | 58 | $9,860 | $3,155 | 32.0% |
About Dr. Ritu Varma, M.D
Dr. Ritu Varma, M.D is a Pain Medicine healthcare provider based in Springfield, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2008. The National Provider Identifier (NPI) number assigned to this provider is 1215112537.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ritu Varma, M.D has received a total of $1,499 in payments from pharmaceutical and medical device companies, with $213.98 received in 2024. These payments were reported across 70 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,478).
As a Medicare-enrolled provider, Varma has provided services to 7,222 Medicare beneficiaries, totaling 16,426 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 129 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Other Specialties Interventional Pain Medicine, Interventional Pain Medicine
- Location Springfield, VA
- Active Since 01/05/2008
- Last Updated 08/13/2025
- Taxonomy Code 208VP0000X
- Entity Type Individual
- NPI Number 1215112537
Products in Payments
- GENERATOR (Device) $163.63
- IFUSE IMPLANT (Device) $140.25
- SEGLENTIS (Drug) $81.38
- VYEPTI (Biological) $78.71
- PROCLAIM (Device) $76.36
- XTAMPZA (Drug) $72.06
- Horizant (Drug) $67.35
- Belbuca (Drug) $62.34
- SPECTRA WAVEWRITER (Device) $60.26
- DUEXIS (Drug) $50.41
- Movantik (Drug) $48.19
- Iovera (Device) $42.56
- Seglentis (Drug) $41.00
- HYSINGLA ER (Drug) $40.89
- GENERAL - PAIN MANAGEMENT (Device) $37.05
- Xtampza ER (Drug) $34.87
- RESTORE (Device) $29.49
- iFuse Implant (Device) $26.87
- ZTLido (Drug) $25.00
- PAINTEQ (Device) $24.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Springfield
Omar Ali, M.d, M.D
Pain Medicine — Payments: $65,691
Dr. Ronald Ellis, Md, MD
Pain Medicine — Payments: $26,701
Dr. Benjamin Lampert, Md, MD
Pain Medicine — Payments: $16,203
Dr. James Bresnahan, M.d, M.D
Pain Medicine — Payments: $10,746
Chukwudi Chiaghana, M.d, M.D
Pain Medicine — Payments: $8,933
Ashish Malik
Pain Medicine — Payments: $4,161